Propofol suppresses cell proliferation in gastric cancer cells through NRF2-mediated polyol pathway.

Cao, Yajun; Fan, Long; Li, Linkai; Zhou, Jiexian

Cao, Yajun; Fan, Long; Li, Linkai; Zhou, Jiexian.

Affiliation

Cao Y; Department of Anesthesia, Zhuhai Center for Maternal and Child Health Care, Zhuhai, China.
Fan L; Department of Pharmacy, Zhuhai Center for Maternal and Child Health Care, Zhuhai, China.
Li L; Department of Pharmacy, Zhuhai Center for Maternal and Child Health Care, Zhuhai, China.
Zhou J; Department of Anesthesia, Zhuhai Center for Maternal and Child Health Care, Zhuhai, China.

Clin Exp Pharmacol Physiol ; 49(2): 264-274, 2022 02.

Article in En | MEDLINE | ID: mdl-34570396

Subject(s)

Propofol; Stomach Neoplasms; Aldehyde Reductase/pharmacology; Cell Line, Tumor; Cell Proliferation; Humans; NF-E2-Related Factor 2/metabolism; Polymers; Propofol/pharmacology; Stomach Neoplasms/drug therapy

Key words

NRF2; cell proliferation; gastric cancer cell; polyol pathway; propofol

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Propofol Limits: Humans Language: En Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Propofol Limits: Humans Language: En Year: 2022 Type: Article